Hermetica Superfood Encyclopedia
The Short Answer
Chaetoceros muelleri produces sulfated polysaccharides (CMSP), carotenoids, phenolics, and beta-glucans as its primary documented bioactive compounds, exerting antioxidant activity through DPPH radical scavenging and FRAP mechanisms rather than through ascorbic acid. Critically, no peer-reviewed evidence establishes measurable vitamin C (ascorbic acid) content in C. muelleri biomass; CMSP achieved only 23% DPPH radical scavenging compared to 84% for vitamin C used as a positive control, underscoring that this alga is not a validated vitamin C source.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordChaetoceros muelleri benefits
Chaetoceros muelleri — botanical close-up
Health Benefits
**Antioxidant Activity via Sulfated Polysaccharides**: CMSP extracted at 2
2% yield from dry biomass demonstrated 23% DPPH radical scavenging activity after 30-minute incubation at 517 nm, suggesting moderate free-radical neutralization capacity attributable to sulfate functional groups rather than ascorbic acid.
**Phenolic-Mediated Antioxidant Potential**: Total phenolic content up to 89
38 ± 6.21 mg GAE/L measured in standard F/2 culture medium, with FRAP values reaching 94.87 ± 4.44 µM Trolox equivalents under nitrogen-deprivation conditions, indicating condition-dependent antioxidant contribution.
**Non-Cytotoxic Profile in Intestinal Cells**
CMSP extract showed no cytotoxicity in CCD-841 CoN human colon epithelial cells, with cell proliferation maintained at 91–116% across tested concentrations, suggesting a favorable safety margin for gastrointestinal exposure.
**Carotenoid Accumulation**: C
muelleri accumulates carotenoids at concentrations up to 7.3 µg L⁻¹ under specific antibiotic-exposure conditions, with carotenoids known to contribute to antioxidant defense and potential photoprotective activity, though yield is low relative to dedicated carotenoid microalgae.
**Low Glycemic Index Polysaccharide Source**
The extracted CMSP fraction carries a reported glycemic index of 49, classifying it as a low-GI carbohydrate polymer, which may have relevance for metabolic health applications if future clinical data emerge.
**Bioremediation-Associated Biomass Utility**: C
muelleri demonstrates tolerance to environmental antibiotics including sulfamethoxazole and ofloxacin up to 20–30 mg L⁻¹ without significant loss of protein or carotenoid content, indicating biochemical resilience relevant to controlled production purity.
**Protein and Beta-Glucan Content**: Like other diatoms, C
muelleri contains structural beta-glucans and extractable protein fractions, compounds documented in related microalgae species to support immune modulation and gut health, though species-specific quantification and clinical validation for C. muelleri remain absent.
Origin & History
Natural habitat
Chaetoceros muelleri is a marine diatom microalgae found in temperate to tropical coastal ocean environments, including documented cultivation from Sea of Cortez source waters in northwestern Mexico. It is commercially cultivated in controlled photobioreactor systems using nutrient-rich media such as Guillard's F/2 medium, with growth optimized under precise salinity, light, and temperature conditions. The species is primarily harvested for aquaculture feed and biomass research, with no established agricultural tradition as a human nutritional supplement source.
“Chaetoceros muelleri has no documented history of use in any traditional medicine system — Ayurvedic, Traditional Chinese Medicine, Indigenous American, or otherwise — and no cultural or ethnobotanical record of human consumption as food or medicine exists for this species. The diatom has been studied since the mid-20th century primarily in marine biology and aquaculture science as a feed organism for bivalve larvae and other filter feeders, representing a purely industrial and ecological context rather than a medicinal one. Contemporary scientific interest has shifted toward its biomass as a source of antioxidant polysaccharides and for bioremediation of pharmaceutical pollutants in wastewater, neither of which constitutes a traditional use. The association of C. muelleri with vitamin C supplementation appears to be a modern commercial framing unsupported by historical precedent or validated compositional analysis.”Traditional Medicine
Scientific Research
The body of evidence for Chaetoceros muelleri as a nutritional or medicinal ingredient is extremely limited, consisting exclusively of in vitro laboratory studies with no human clinical trials, animal studies, or even ex vivo tissue experiments reported in the peer-reviewed literature as of the available evidence base. Existing studies document CMSP polysaccharide extraction and characterization, phenolic content measurement across varying nutrient conditions, carotenoid quantification under antibiotic exposure, and cytotoxicity screening in a single colon cell line (CCD-841 CoN), none of which constitute clinical evidence for human health benefit. Crucially, no study has quantified vitamin C (ascorbic acid) in C. muelleri biomass, and the antioxidant activity of CMSP (23% DPPH) was benchmarked against vitamin C as a positive control at 84%, explicitly demonstrating that CMSP does not match or substitute for ascorbic acid. Any commercial claim positioning C. muelleri as an 'exceptionally high vitamin C source' is entirely unsupported by the current scientific literature and should be treated with strong skepticism pending rigorous analytical and clinical investigation.
Preparation & Dosage
Traditional preparation
**Laboratory Biomass Culture**
Grown in Guillard's F/2 modified seawater medium under controlled light and temperature; not a standardized consumer preparation method.
**CMSP Polysaccharide Extract**
Isolated from dry biomass at approximately 2.2% w/w yield via aqueous extraction and precipitation; characterized by FTIR and SEM but not formulated for supplemental use.
**No Established Supplement Form**
No capsule, powder, tablet, or liquid extract of C. muelleri is formally standardized for human nutritional use with defined vitamin C content.
**No Clinically Validated Dose**
No effective dose range has been established from human studies; all in vitro concentrations are not translatable to supplement dosing guidance without further research.
**Traditional Preparation**
None documented; C. muelleri has no history of traditional human consumption or preparation as a food or medicine.
**Research Caution**
Consumers should not assume that whole algae biomass products labeled as containing C. muelleri provide meaningful vitamin C, as no ascorbic acid content has been analytically confirmed in this species.
Nutritional Profile
Chaetoceros muelleri biomass contains structural beta-glucans as cell wall polysaccharides, sulfated heteropolysaccharides (CMSP at ~2.2% dry weight), extractable protein fractions (specific percentages not formally published for this species in available literature), and carotenoid pigments at low concentrations (up to 7.3 µg L⁻¹ in culture medium under antibiotic conditions). Phenolic compounds contribute a total phenolic content of up to 89.38 ± 6.21 mg GAE/L under optimal growth conditions, with FRAP antioxidant potential reaching 94.87 ± 4.44 µM Trolox equivalents under nitrogen stress. Vitamin C (ascorbic acid) has not been quantified in this species, and no reliable concentration data exist for macronutrients (carbohydrates, lipids, protein as percentage of dry weight) specific to C. muelleri in nutritionally focused publications. Bioavailability of its polysaccharides and phenolics in the human gastrointestinal tract has not been studied, and matrix effects from the diatom silica frustule cell wall may affect nutrient release.
How It Works
Mechanism of Action
The primary documented mechanism of antioxidant action in Chaetoceros muelleri extracts involves sulfated polysaccharide (CMSP) hydrogen donation and electron transfer to stabilize DPPH free radicals, a process confirmed in vitro at 517 nm absorbance with 23% scavenging efficiency; the irregular, non-acute particle microstructure observed under scanning electron microscopy and sulfate group vibrations confirmed by FTIR bands at 3405–590 cm⁻¹ are hypothesized to facilitate this radical quenching. Phenolic compounds present in the biomass contribute additional antioxidant capacity through the FRAP mechanism, donating electrons to reduce ferric iron complexes, with activity modulated by nitrogen and silicon availability in the growth medium. No vitamin C (ascorbic acid)-specific molecular mechanism — including collagen hydroxylation via prolyl hydroxylase, immune cell activation, or iron absorption enhancement — has been documented for C. muelleri, because ascorbic acid has not been quantified or confirmed as a constituent of this species. The species' tolerance to antibiotic compounds suggests constitutive cellular defense pathways, but the molecular targets and gene expression changes underlying this resilience have not been elucidated in published literature.
Clinical Evidence
No clinical trials of any design — randomized controlled, observational, or pilot — have been conducted evaluating Chaetoceros muelleri extracts, its polysaccharides, or any purported vitamin C fraction in human subjects. All available outcome data derive from in vitro cell culture assays: CMSP showed non-cytotoxic behavior in human colon epithelial cells (91–116% proliferation across concentrations) and 23% DPPH scavenging activity, while phenolic fractions reached FRAP values of 94.87 ± 4.44 µM TE under specific stress conditions. No effect sizes, confidence intervals, biomarker changes, or patient-reported outcomes exist. Confidence in any human health benefit claim is negligible, and regulatory-grade clinical evidence would require validated ascorbic acid quantification followed by pharmacokinetic, dose-ranging, and efficacy studies before any therapeutic conclusion could be drawn.
Safety & Interactions
Chaetoceros muelleri extracts showed no cytotoxicity in human CCD-841 CoN colon epithelial cells across tested CMSP concentrations (91–116% proliferation), and whole biomass protein and carotenoid content remained stable up to 20 mg L⁻¹ antibiotic exposure in culture, suggesting a low acute toxicity profile in vitro. However, no human safety data — including maximum tolerated dose, adverse event profiles, or pharmacovigilance reports — exist for any C. muelleri preparation consumed as a nutritional supplement. No drug interaction studies have been conducted; given the sulfated polysaccharide content, theoretical interactions with anticoagulant medications (e.g., warfarin, heparin) cannot be excluded, as sulfated polysaccharides from other marine sources are known to have heparin-like activity at sufficient doses. Guidance for pregnancy, lactation, pediatric use, or immunocompromised individuals cannot be provided due to a complete absence of relevant safety research; use as a vitamin C supplement is not recommended given the lack of confirmed ascorbic acid content.
Synergy Stack
Hermetica Formulation Heuristic
Featured in
Meru
Marine collagen with hyaluronic acid for skin, hair & joints.
Shop Now →
Also Known As
Chaetoceros muelleri LemmermannCMSP source organismChaetoceros muelleriimarine diatom microalgaeChaetoceros muelleri (marine diatom microalga)
Frequently Asked Questions
Does Chaetoceros muelleri actually contain vitamin C?
No peer-reviewed study has quantified vitamin C (ascorbic acid) in Chaetoceros muelleri biomass. In fact, research has used vitamin C as a positive control to benchmark CMSP polysaccharide antioxidant activity, finding CMSP achieved only 23% DPPH radical scavenging compared to 84% for vitamin C, which demonstrates the alga does not match ascorbic acid activity. Claims of 'exceptionally high vitamin C' from this species are not supported by current scientific literature.
What are the actual bioactive compounds in Chaetoceros muelleri?
The documented bioactive compounds in C. muelleri include sulfated polysaccharides (CMSP, extracted at 2.2% dry biomass yield), phenolic compounds (up to 89.38 ± 6.21 mg GAE/L in culture medium), carotenoid pigments (up to 7.3 µg L⁻¹), beta-glucans, and protein fractions. These compounds exhibit moderate antioxidant activity via DPPH radical scavenging and FRAP mechanisms, but none have been clinically validated for human health benefits.
Is Chaetoceros muelleri safe to take as a supplement?
In vitro testing of CMSP extract showed no cytotoxicity in human colon epithelial cells (CCD-841 CoN) with cell proliferation maintained at 91–116% across tested concentrations, suggesting low acute toxicity in laboratory conditions. However, no human clinical safety data exist, and maximum safe doses, drug interactions, and contraindications for pregnancy or immunocompromised individuals have not been studied. Until human safety research is conducted, supplemental use cannot be formally endorsed.
What is Chaetoceros muelleri primarily researched for scientifically?
Current scientific research on C. muelleri focuses on three main areas: its sulfated polysaccharides (CMSP) as antioxidant and potentially low-glycemic carbohydrate polymers, its use as an aquaculture feed organism for bivalve larvae, and its potential for bioremediation of pharmaceutical pollutants including antibiotics like sulfamethoxazole and ofloxacin in wastewater systems. Nutritional supplementation for human health is not a primary research focus, and no clinical trials have been conducted.
How does Chaetoceros muelleri compare to other microalgae as an antioxidant source?
Compared to widely studied antioxidant microalgae like Haematococcus pluvialis (astaxanthin source, up to 4% dry weight) or Spirulina platensis (phycocyanin, established antioxidant activity), C. muelleri's documented antioxidant output is modest, with CMSP achieving only 23% DPPH scavenging versus 84% for ascorbic acid in the same assay. Its total phenolic content of up to 89.38 mg GAE/L is nutritionally relevant but not exceptional among microalgae. C. muelleri currently lacks the clinical evidence base that supports antioxidant claims for Spirulina or Chlorella.
What is the difference between Chaetoceros muelleri vitamin C and synthetic ascorbic acid?
Chaetoceros muelleri does not contain significant ascorbic acid; instead, its antioxidant activity comes from sulfated polysaccharides (CMSP) and phenolic compounds that provide free-radical scavenging through different mechanisms than vitamin C. While synthetic ascorbic acid is a water-soluble reducing agent, the polysaccharide and phenolic fractions in Chaetoceros muelleri work via sulfate group interactions and phenolic hydroxyl groups. This makes Chaetoceros muelleri functionally a polysaccharide-based antioxidant extract rather than a true vitamin C source.
How much of Chaetoceros muelleri's antioxidant activity comes from its actual bioavailable compounds?
The sulfated polysaccharide fraction (CMSP) yields approximately 2.2% by dry biomass weight and demonstrates moderate DPPH radical scavenging activity (23% at 517 nm), while phenolic compounds reach up to 89.38 mg/g—indicating that phenolics are the primary quantifiable antioxidant constituents. However, in vivo bioavailability of these polysaccharides and phenolics remains understudied, and the 23% DPPH scavenging suggests moderate rather than superior antioxidant potency compared to concentrated vitamin C or other antioxidant sources. Actual bioavailable antioxidant impact depends on gut absorption rates and metabolism of these larger molecular structures.
Is Chaetoceros muelleri better absorbed than other microalgae extracts for antioxidant benefits?
Direct absorption comparisons between Chaetoceros muelleri and other microalgae extracts are limited in published literature, though its sulfated polysaccharide structure suggests potential for prebiotic effects and enhanced bioavailability through microbial fermentation in the colon. The phenolic content (up to 89.38 mg/g) is comparable to land plant sources, but microalgal cell walls may present bioavailability challenges similar to other algal supplements. Most clinical efficacy data focuses on ex vivo antioxidant assays rather than human absorption studies, making direct bioavailability claims premature.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w vitamin-c-from-chaetoceros-muelleri-chaetoceros-muelleri-microalgae curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
